JNJ stock faces pressure despite strong earnings and dividend growth. Explore how s&p today trends and sector rotation impact this healthcare giant’s market position.

Johnson & Johnson (JNJ) stock rises after Leerink Partners upgrades the company to Outperform, citing its growth prospects. Read more here.

Johnson & Johnson has outperformed the broader market over the past year, and Wall Street analysts maintain a moderately ...

We just covered the 15 Safe Stocks to Invest In For Beginners and Johnson & Johnson (NYSE:JNJ) ranks 5th on this list. Johnson & Johnson (NYSE:JNJ) has transformed from a slow-growth conglomerate into ...

Johnson & Johnson (JNJ) is back on many investors’ screens after recent share price moves, with the stock down about 6% over the past month and roughly flat over the past 3 months. See our latest ...

The intrinsic value estimate for Johnson & Johnson has shifted slightly, with the fair value moving from US$252.42 to ...

Deandre Ayton #5 reacts after a basket by Nick Smith Jr. #20 of the Los Angeles Lakers against the Portland Trail Blazers at Moda Center on Novembe ...

Oppenheimer reiterates Nvidia as outperform Oppenheimer said it's bullish ahead of earnings next week. "We expect NVDA CY26 ...

Fintel reports that on May 13, 2026, Leerink Partners upgraded their outlook for Johnson & Johnson (NYSE:JNJ) from Market Perform to Outperform. Analyst Price Forecast Suggests 12.12% Upside As of ...

We just covered the 15 Safe Stocks to Invest In For Beginners and Johnson & Johnson (NYSE:JNJ) ranks 5th on this list. Johnson & Johnson (NYSE:JNJ) has transformed from a slow-growth conglomerate into ...

Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.